Drugs News and Research

RSS

Scientists join forces to identify a new approach to fight African sleeping sickness

Scientists working in a range of disciplines joined forces to identify a new approach to combat African sleeping sickness. Fundamental research undertaken under the supervision of Professor Ute Hellmich of Johannes Gutenberg University Mainz has revealed a promising strategy to develop a suitable agent.

20 Feb 2019

Elevated levels of key cellular process implicated in intestinal inflammation and IBD

Elevated levels of the key cellular process of apoptosis have been implicated in intestinal inflammation and inflammatory bowel disease in a new study from the Quadram Institute.

20 Feb 2019

Machine learning technique helps predict which asthma patients respond to corticosteroid therapy

Physicians will be able to predict which of their patients with severe asthma are likely to benefit from treatment with systemic corticosteroids -- and which might only suffer their side effects -- with help from a dozen clinical variables researchers have identified using machine learning techniques.

20 Feb 2019

Researchers engineer stem cell with ‘suicide genes’ to induce cell death in all but beta cells

Researchers have been advancing methods to generate insulin-producing beta cells from pluripotent stem cells for the clinical treatment of type 1 diabetes.

20 Feb 2019

University of Dundee partners with Takeda to develop new treatments for tau pathology

The University of Dundee Drug Discovery Unit has announced a partnership with Takeda, Japan's largest pharmaceutical company, to develop possible new therapeutic treatments for tau pathology, an underlying feature in several forms of neurodegeneration, including Alzheimer's disease.

20 Feb 2019

Researchers uncover biochemical pathway that may help identify drugs to treat Alzheimer's

Researchers have uncovered an enzyme and a biochemical pathway they believe may lead to the identification of drugs that could inhibit the production of beta-amyloid protein, the toxic initiator of Alzheimer's disease.

20 Feb 2019

New screening tool more likely to identify sexual and labor exploitation of youth

A screening tool designed specifically to assess for human trafficking was more likely to identify sexual and labor exploitation of youth, as well as the risk factors, than a commonly used psychosocial assessment, reported researchers from The University of Texas Health Science Center at Houston and Baylor College of Medicine.

20 Feb 2019

Researchers take closer look at how viruses bind cells and cause infection

Researchers at Cardiff University have used x-ray crystallography and computer simulation to get a closer look at how viruses bind cells and cause infection.

20 Feb 2019

New forms of older anti-cancer agent appear to enhance immune response to fight melanoma

Researchers at the Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins and the Johns Hopkins University School of Medicine report two new forms of an older anti-cancer agent they developed appear to enhance the immune system's ability to fight melanoma in mice.

20 Feb 2019

Researchers unlock plant’s secret of producing specialized metabolites

Plants are master chemists, and Michigan State University researchers have unlocked their secret of producing specialized metabolites.

20 Feb 2019

Study suggests new treatment strategy for deadly brain cancer

In a study of mice and human brain tumors researchers at the University of the Michigan, Ann Arbor, searched for new treatments by exploring the reasons why some patients with gliomas live remarkably longer than others.

19 Feb 2019

Common acid reflux drugs tied to elevated risk for kidney disease

Proton pump inhibitors, which include well-known brand names Prilosec, Nexium and Prevacid, are among the most commonly prescribed medications in the world. Approximately 10 percent of adults in the United States take these drugs for frequent heartburn, acid reflux and gastroesophageal reflux disease.

19 Feb 2019

First molecular test predicts treatment response for kidney cancer

Immunotherapy drugs such as PD-L1 checkpoint inhibitors represent the front-line treatment for kidney cancer. But immunotherapy is expensive, benefits only a subset of patients and is futile in the majority of patients.

19 Feb 2019

Anti-cancer immunotherapy could be used to fight HIV

Researchers at the University of Montreal Hospital Research Centre have shown that immunotherapy treatments against cancer could reduce the amount of virus that persists in people on triple therapy.

19 Feb 2019

Brain imaging indicates potential success of drug therapy in depressive patients

Working with international partners, a MedUni Vienna research group has shown that imaging techniques carried out prior to treatment indicate the potential success of drug therapy in depressive patients.

19 Feb 2019

For 2020 Dem hopefuls, ‘Medicare-for-all’ is a defining issue, however they define it

Democrats with 2020 presidential aspirations are courting the party's increasingly influential progressive wing and staking out ambitious policy platforms.

19 Feb 2019

The high cost of sex: Insurers often don’t pay for drugs to treat problems

For some older people, the joy of sex may be tempered by financial concerns: Can they afford the medications they need to improve their experience between the sheets?

19 Feb 2019

New study establishes how stress favors breast cancer growth and spread

Cancer: The word alone evokes dread, anxiety, and fear. Accordingly, many women living with the disease and undergoing treatment experience chronic stress and depression.

19 Feb 2019

Early marker of cardiac damage triggered by cancer treatment identified

Every year, 4 million new cases of cancer are diagnosed in Europe. Advances in cancer treatment sometimes come at the cost of major adverse effects, and one of the most prominent is cardiotoxicity. Myocardial toxicity affects as many as 25% of patients undergoing treatment with commonly used anticancer drugs.

19 Feb 2019

Using light-based method for production of pharmaceutical molecules

Photoelectrochemical cells are widely studied for the conversion of solar energy into chemical fuels. They use photocathodes and photoanodes to "split" water into hydrogen and oxygen respectively.

18 Feb 2019

Drugs News and Research

Scientists join forces to identify a new approach to fight African sleeping sickness

Elevated levels of key cellular process implicated in intestinal inflammation and IBD

Machine learning technique helps predict which asthma patients respond to corticosteroid therapy

Researchers engineer stem cell with ‘suicide genes’ to induce cell death in all but beta cells

University of Dundee partners with Takeda to develop new treatments for tau pathology

Researchers uncover biochemical pathway that may help identify drugs to treat Alzheimer's

New screening tool more likely to identify sexual and labor exploitation of youth

Researchers take closer look at how viruses bind cells and cause infection

New forms of older anti-cancer agent appear to enhance immune response to fight melanoma

Researchers unlock plant’s secret of producing specialized metabolites

Study suggests new treatment strategy for deadly brain cancer

Common acid reflux drugs tied to elevated risk for kidney disease

First molecular test predicts treatment response for kidney cancer

Anti-cancer immunotherapy could be used to fight HIV

Brain imaging indicates potential success of drug therapy in depressive patients

For 2020 Dem hopefuls, ‘Medicare-for-all’ is a defining issue, however they define it

The high cost of sex: Insurers often don’t pay for drugs to treat problems

New study establishes how stress favors breast cancer growth and spread

Early marker of cardiac damage triggered by cancer treatment identified

Using light-based method for production of pharmaceutical molecules

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News